Sanofi Enterprise Value:
156.12B for May 17, 2013Sanofi Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 156.12B |
| May 16, 2013 | 156.12B |
| May 15, 2013 | 156.85B |
| May 14, 2013 | 157.65B |
| May 13, 2013 | 157.79B |
| May 10, 2013 | 158.13B |
| May 9, 2013 | 156.36B |
| May 8, 2013 | 157.68B |
| May 7, 2013 | 154.57B |
| May 6, 2013 | 152.99B |
| May 3, 2013 | 159.96B |
| May 2, 2013 | 158.24B |
| May 1, 2013 | 152.53B |
| April 30, 2013 | 153.82B |
| April 29, 2013 | 156.90B |
| April 26, 2013 | 153.84B |
| April 25, 2013 | 153.66B |
| April 24, 2013 | 157.54B |
| April 23, 2013 | 156.31B |
| April 22, 2013 | 152.21B |
| April 19, 2013 | 152.77B |
| April 18, 2013 | 151.67B |
| April 17, 2013 | 151.38B |
| April 16, 2013 | 156.55B |
| April 15, 2013 | 155.08B |
| April 12, 2013 | 151.35B |
| April 11, 2013 | 151.86B |
| April 10, 2013 | 150.84B |
| April 9, 2013 | 148.99B |
| April 8, 2013 | 147.51B |
| April 5, 2013 | 146.60B |
| April 4, 2013 | 148.37B |
| April 3, 2013 | 149.26B |
| April 2, 2013 | 150.09B |
| April 1, 2013 | 147.41B |
| March 28, 2013 | 147.73B |
| March 27, 2013 | 145.23B |
| March 26, 2013 | 146.28B |
| March 25, 2013 | 144.83B |
| March 22, 2013 | 146.68B |
| March 21, 2013 | 144.73B |
| March 20, 2013 | 146.79B |
| March 19, 2013 | 142.77B |
| March 18, 2013 | 142.26B |
| March 15, 2013 | 144.70B |
| March 14, 2013 | 142.96B |
| March 13, 2013 | 142.34B |
| March 12, 2013 | 142.12B |
| March 11, 2013 | 142.39B |
| March 8, 2013 | 143.25B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
SNY Enterprise Value Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 165.77B |
| Novartis | 199.34B |
| Eli Lilly and Company | 63.75B |
SNY Enterprise Value Rankings
| Overall |
99th percentile 36 of 8007 |
| Sector |
99th percentile 5 of 685 in Healthcare |
| Industry |
90th percentile 5 of 54 in Drug Manufacturers - Major |
SNY Enterprise Value Range, Past 5 Years
| Minimum | 68.07B | Mar 6 2009 |
| Maximum | 159.96B | May 3 2013 |
| Average | 107.87B |
